Societal Impact of Research Funding for Women's Health in Alzheimer's Disease and Alzheimer's Disease–Related Dementias
Apr 22, 2021
Using microsimulation analyses, researchers examined the impact of increasing funding for women's health research, with a focus on the following three disease areas: brain health, immune and autoimmune disease, and cardiovascular disease. They found that large societal gains may be possible by increasing investment in women's health research.
Women's health has suffered from insufficient research addressing women. The research community has not widely embraced the value of this research, and the impact of limited knowledge about women's health relative to men's is far-reaching. Without information on the potential return on investment for women's health research, research funders, policymakers, and business leaders lack a basis for altering research investments to improve knowledge of women's health.
As part of an initiative of the Women's Health Access Matters (WHAM) nonprofit foundation, RAND Corporation researchers examined the impact of increasing funding for women's health research, with a focus on the following three disease areas: brain health, immune and autoimmune disease, and cardiovascular disease. Using microsimulation analyses, the research team studied the societal cost impact of increasing research funding in three diseases that present a large disease burden for women: Alzheimer's disease and Alzheimer's disease–related dementias (AD/ADRD), coronary artery disease (CAD), and rheumatoid arthritis (RA).
The results establish the potential for investment in women's health research to realize gains beyond additional general research investment and point the way to a concrete, actionable research and funding agenda.